Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy

Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy

Background: Currently, 45–55% of rectal cancer patients receive preoperative chemo- radio-therapy for Locally Advanced Rectal Cancer (LARC). The idea of our study is to use Electrochemotherapy (ECT) before surgery, in patients with major clinical response after neoadjuvant therapy, to allow for a mo...

Full description

Bibliographic Details
Main Authors: Daniela Rega, Vincenza Granata, Antonella Petrillo, Ugo Pace, Cinzia Sassaroli, Massimiliano Di Marzo, Carmela Cervone, Roberta Fusco, Valeria D’Alessio, Guglielmo Nasti, Carmela Romano, Antonio Avallone, Biagio Pecori, Gerardo Botti, Fabiana Tatangelo, Piera Maiolino, Paolo Delrio
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
electrochemotherapy
locally advanced rectal cancer
endoluminal electrodes
conservative surgery
total mesorectal excision
Online Access:https://www.mdpi.com/2072-6694/13/13/3199

Internet

https://www.mdpi.com/2072-6694/13/13/3199

Similar Items